JDD July Issue Highlights | Skin of Color Issue
The July issue of the Journal of Drugs in Dermatology (JDD) focuses on skin of color topics with the perfect mix of original articles, case reports, brief communications, and letters to the editor. Among many of the topics explored in this issue are skin of color dermatology on TikTok, disparities in melanoma recognition in skin …
Continue reading “JDD July Issue Highlights | Skin of Color Issue”
PRP for Scarring Alopecia Due to Discoid Lupus Erythematosus (DLE)
JDD authors Hannah Polster MD, Karen Kagha MD, and Janiene Luke MD report a case of platelet rich plasma for the treatment of scarring alopecia due to discoid lupus erythematosus. Platelet-rich plasma (PRP) is an autologous concentration of plasma from a patient’s blood containing platelets up to 7 times higher than normal plasma.1 Originally indicated …
Continue reading “PRP for Scarring Alopecia Due to Discoid Lupus Erythematosus (DLE)”
JDD Issue Highlights | June 2022: Acne & Rosacea
The June 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on acne and rosacea, with original articles discussing topics such as improving rosacea outcomes in skin of color patients, pediatric and female acne, topical management of facial and truncal acne, and many more. Included in this issue are also case reports on …
Continue reading “JDD Issue Highlights | June 2022: Acne & Rosacea”
Successful Treatment of Cheilitis Granulomatosa With Certolizumab and Ustekinumab
INTRODUCTION Cheilitis granulomatosa (CG) is a subtype of orofacial granulomatosis that results in facial and oral swelling in the absence of non-caseating granulomatous systemic diseases such as Crohn’s and sarcoidosis.1 With concurrent facial palsy and a plicated tongue, the condition is referred to as Melkersson-Rosenthal syndrome.1,2 Both CG and Melkersson-Rosenthal syndrome are in the orofacial granulomatosis family …
Continue reading “Successful Treatment of Cheilitis Granulomatosa With Certolizumab and Ustekinumab”
JDD Issue Highlights | May 2022
The May 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on skin cancer and features other topics such as fungal infections, updates on new topical advances, and Mohs micrographic surgery. We share this month’s issue highlights straight from the JDD Editor’s desk: Insights in Skin of Color Patients With Atopic Dermatitis and …
An Analysis of Skin of Color Publications in the Journal of Drugs in Dermatology
INTRODUCTION As the United States population becomes increasingly diverse, it is exceedingly important for dermatologists to be knowledgeable about treating patients with skin of color (SOC). The published literature is an especially valuable resource for treating SOC. Many prevalent dermatological conditions, such as acne vulgaris, atopic dermatitis, and psoriasis, differ histologically and/or clinically in SOC, …
Continue reading “An Analysis of Skin of Color Publications in the Journal of Drugs in Dermatology”
Intralesional Bleomycin Combined With Cryotherapy in the Treatment of Recalcitrant Verruca Vulgaris
Verruca vulgaris is a common cutaneous manifestation of Human Papillomavirus (HPV) infection that presents as hyperkeratotic, cauliflower-like papules with central black petechiae. These lesions may be resistant to conventional therapies, posing a therapeutic challenge and prolong significant morbidity for the patient. This case report demonstrates an immediate and robust response of recalcitrant warts to intralesional …
For Sale Now! Digital Edition of The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas
We have exciting news! The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas DIGITAL EDITION is now available for purchase! The atlas displays side-by-side images of the most commonly seen dermatology conditions in an array of skin tones and features: Real patients - real skin. No computer generated images 650+ full spectrum, side by side …
JDD Issue Highlights | April 2022
The April 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from injectable fillers, botulinum toxin in hidradenitis suppurativa, cannabis and cannabinoid product use, to psoriasis, melasma, onychomycosis and everything in between, we share this month’s issue highlights straight from …
Most Patient-Oriented Video Resources Do Not Comprehensively Explain Mohs Micrographic Surgery
INTRODUCTION Mohs micrographic surgery (MMS) is increasingly utilized for treatment of skin cancer, however the technique used is markedly different than other surgical modalities.1,2 Explaining MMS to patients is difficult, and anxiety following a skin cancer diagnosis likely leads many to seek out additional resources to supplement their understanding.3,4 It is unclear how accurate and …